The Runx2 osteogenic transcription factor regulates matrix metalloproteinase 9 in bone metastatic cancer cells and controls cell invasion

被引:255
作者
Pratap, J
Javed, A
Languino, LR
van Wijnen, AJ
Stein, JL
Stein, GS
Lian, JB
机构
[1] Univ Massachusetts, Sch Med, Dept Cell Biol, Worcester, MA 01655 USA
[2] Univ Massachusetts, Sch Med, Dept Canc Biol, Worcester, MA 01655 USA
[3] Univ Massachusetts, Sch Med, Ctr Canc, Worcester, MA 01655 USA
关键词
D O I
10.1128/MCB.25.19.8581-8591.2005
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
The Runx2 (Cbfal/AML3) transcription factor and matrix metalloproteinase 9 (MMP9) are key regulators of growth plate maturation and bone formation. The genes for both proteins are characteristic markers of breast and prostate cancer cells that metastasize to bone. Here we experimentally addressed the compelling question of whether Runx2 and MMP are functionally linked. By cDNA expression array analysis, we identified MMP9 as a novel downstream target of Runx2. Like that of MMP13, MMP9 expression is nearly depleted in Runx2 mutant mice. Chromatin immunoprecipitation and electrophoretic mobility shift assays revealed the recruitment of Runx2 to the MMP9 promoter. We show by mutational analysis that the Runx2 site mediates transactivation of the MMP9 promoter in osteoblasts (MC3T3-E1) and nonosseous (HeLa) cells. The overexpression of Runx2 by adenovirus delivery in nonmetastatic (MCF-7) and metastatic breast (MDA-MB-231) and prostate (PC3) cancer cell lines significantly increases the endogenous levels of MMP9. The knockdown of Runx2 by RNA interference decreases MMP9 expression, as well as that of other Runx2 target genes, including the genes for MMP13 and vascular endothelial growth factor. Importantly, we have demonstrated using a cell invasion assay that Runx2-regulated MMP9 levels are functionally related to the invasion properties of cancer cells. These results are consistent with Runx2 control of multiple genes that contribute to the metastatic properties of cancer cells and their activity in the bone microenvironment.
引用
收藏
页码:8581 / 8591
页数:11
相关论文
共 65 条
  • [11] Subnuclear targeting of Runx/Cbfa/AML factors is essential for tissue-specific differentiation during embryonic development
    Choi, JY
    Pratap, J
    Javed, A
    Zaidi, SK
    Xing, LP
    Balint, E
    Dalamangas, S
    Boyce, B
    van Wijnen, AJ
    Lian, JB
    Stein, JL
    Jones, SN
    Stein, GS
    [J]. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2001, 98 (15) : 8650 - 8655
  • [12] Regulation of VEGF/VPF expression in tumor cells: Consequences for tumor growth and metastasis
    Claffey, KP
    Robinson, GS
    [J]. CANCER AND METASTASIS REVIEWS, 1996, 15 (02) : 165 - 176
  • [13] Cancer therapy - Matrix metalloproteinase inhibitors and cancer: Trials and tribulations
    Coussens, LM
    Fingleton, B
    Matrisian, LM
    [J]. SCIENCE, 2002, 295 (5564) : 2387 - 2392
  • [14] Physical interaction of the activator protein-1 factors c-Fos and c-Jun with Cbfa1 for collagenase-3 promoter activation
    D'Alonzo, RC
    Selvamurugan, N
    Karsenty, G
    Partridge, NC
    [J]. JOURNAL OF BIOLOGICAL CHEMISTRY, 2002, 277 (01) : 816 - 822
  • [15] ACCURATE TRANSCRIPTION INITIATION BY RNA POLYMERASE-II IN A SOLUBLE EXTRACT FROM ISOLATED MAMMALIAN NUCLEI
    DIGNAM, JD
    LEBOVITZ, RM
    ROEDER, RG
    [J]. NUCLEIC ACIDS RESEARCH, 1983, 11 (05) : 1475 - 1489
  • [16] The biology of the Ets1 proto-oncogene
    Jürgen Dittmer
    [J]. Molecular Cancer, 2 (1)
  • [17] Osf2/Cbfa1: A transcriptional activator of osteoblast differentiation
    Ducy, P
    Zhang, R
    Geoffroy, V
    Ridall, AL
    Karsenty, G
    [J]. CELL, 1997, 89 (05) : 747 - 754
  • [18] A Cbfa1-dependent genetic pathway controls bone formation beyond embryonic development
    Ducy, P
    Starbuck, M
    Priemel, M
    Shen, JH
    Pinero, G
    Geoffroy, V
    Amling, M
    Karsenty, G
    [J]. GENES & DEVELOPMENT, 1999, 13 (08) : 1025 - 1036
  • [19] New functions for the matrix metalloproteinases in cancer progression
    Egeblad, M
    Werb, Z
    [J]. NATURE REVIEWS CANCER, 2002, 2 (03) : 161 - 174
  • [20] FINI ME, 1994, J BIOL CHEM, V269, P28620